Literature DB >> 914929

Thin-layer densitometric determination of muzolimine (BAY g 2821), a structurally new diuretic drug, at the nanogram level in biological fluids.

W Ritter.   

Abstract

A sensitive and specific thin-layer densitometric method was developed for the determination of muzolimine (BAY g 2821), a structurally new diuretic drug of the pyrazolinone type. For detection of the drug on thin-layer chromatographic plates, a colour reaction with 4-dimethylaminocinnamaldehyde is carried out. The detection limit was 50 pg per spot on commercially available silica gel 60 plates. A nearly linear relationship between integrated peak area and amount per spot was obtained in the range from 100 pg to 1 mug per spot. For quantitative determination in biological fluids, a recovery of about 100% is achieved by a single extraction with dichloromethane, and the extract is spotted directly on to the plate. The detection limit of muzolimine in plasma and urine was 1 ng/ml, and inaccuracy in the nanogram range was found to be 5-8%. The assay was applied to pharmacokinetic studies and can be recommended for monitoring plasma levels of muzolimine in patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914929     DOI: 10.1016/s0021-9673(01)92056-4

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Comparison of the pharmacodynamic effects of furosemide and BAY g 2821 and correlation of the pharmacodynamics and pharmacokinetics of BAY g 2821 (muzolimine).

Authors:  D Loew; W Ritter; J Dycka
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of some newer diuretics.

Authors:  B Beermann; M Grind
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

3.  Pharmacokinetics of a single oral dose of muzolimine in cardiac failure.

Authors:  O Brørs; S Jacobsen; E Arnesen
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.